Clinical Trials
9 trialsNCT05063552 2026-05-13
Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers
National Cancer Institute (NCI)
Phase 2/3 Active not recruiting
NCT06295731 2026-05-08
HexAgon-HN
Inhibrx Biosciences, Inc
Phase 2/3 Active not recruiting
NCT05050162 2026-05-07
Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer
NRG Oncology
Phase 2/3 Suspended
NCT03952585 2026-05-04
De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer
National Cancer Institute (NCI)
Phase 2/3 Active not recruiting
NCT03258554 2026-02-06
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin
National Cancer Institute (NCI)
Phase 2/3 Completed
NCT04648020 2023-05-31
VOICE
Monopar Therapeutics
Phase 2/3 Terminated
NCT00656513 2019-11-19
Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck Cancer
Radiation Therapy Oncology Group
Phase 2/3 Completed
NCT01434394 2017-08-21
EAGLE
Shanghai Jiao Tong University School of Medicine
Phase 2/3 Completed
NCT00162708 2005-09-13
Very Intense Radiotherapy-Chemotherapy Regimen in Advanced HNSCC
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2/3 Completed